Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MADHVI ATUL RAJPURKAR

Allopathic & Osteopathic Physicians Pediatrics

NPI
1336186824
CMS profile
14866
Location
DETROIT, MI

General Payments · PY2018–2024

$141,481.21

  • Reported across 82 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$25,365.51

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $10,858.75 4
GENZYME CORPORATION $10,313.65 7
Novo Nordisk AS $4,165.00 1
PFIZER INC. $28.11 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $27,670.22 17
PY2019 $22,798.06 29
PY2020 $19,220.00 7
PY2021 $7,572.45 2
PY2022 $26,151.76 8
PY2023 $12,703.21 5
PY2024 $25,365.51 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
GENZYME CORPORATION $157.86 10/05/2024 Food and Beverage Undisputed 01/23/2026 1139696122 CMS
GENZYME CORPORATION $47.60 10/05/2024 Food and Beverage Undisputed 01/23/2026 1139696124 CMS
GENZYME CORPORATION $181.66 10/05/2024 Travel and Lodging Undisputed 01/23/2026 1139696126 CMS
GENZYME CORPORATION $298.95 10/05/2024 Travel and Lodging Undisputed 01/23/2026 1139696128 CMS
GENZYME CORPORATION $167.58 10/05/2024 Travel and Lodging Undisputed 01/23/2026 1139696130 CMS
GENZYME CORPORATION $60.00 10/05/2024 Travel and Lodging Undisputed 01/23/2026 1139696132 CMS
GENZYME CORPORATION $9,400.00 10/05/2024 Consulting Fee Undisputed 01/23/2026 1139696134 CMS
Novo Nordisk AS $4,165.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 1096552427 CMS
Novo Nordisk Inc $2,380.00 02/12/2024 Consulting Fee Undisputed 01/23/2026 1097267719 CMS
Novo Nordisk Inc $1,190.00 03/25/2024 Consulting Fee Undisputed 01/23/2026 1097273552 CMS
Novo Nordisk Inc $6,098.75 04/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097613563 CMS
Novo Nordisk Inc $1,190.00 04/04/2024 Consulting Fee Undisputed 01/23/2026 1097831084 CMS
PFIZER INC. $0.28 12/19/2024 Food and Beverage Undisputed 01/23/2026 1131641026 CMS
PFIZER INC. $27.83 12/19/2024 Food and Beverage Undisputed 01/23/2026 1131641720 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.